According to the U.S. Centers for Disease Control and Prevention, adult vaccination coverage remains well below Healthy People 2020 targets.
Researchers at the University of Arizona say they may have discovered both the origin of the influenza pandemic of 1918 that left 50 million dead worldwide.
Researchers recently conducted a quality improvement project to increase uptake of the influenza vaccine among healthcare personnel at a university student health center.
Update on HIV/AIDS, meningococcal Group B, tetanus, diphtheria, pertussis and dengue vaccines.
A recent study shows that a vaccine typically used to prevent tuberculosis in countries outside of the U.S. could also prevent multiple sclerosis (MS) in people who are in the beginning stages of the disease.
Pfizer has paid $25 million for the license rights to an experimental, preclinical drug designed to replace pooled intravenous immune globulin (IVIG) therapy to treat autoimmune diseases.
The Advisory Committee on Immunization Practices (ACIP) approved the Recommended Immunization Schedule for Adults Aged 19 Years or Older for 2014.
The Centers for Medicare & Medicaid Services (CMS) has delayed the new “two midnight” rule for Medicare hospital admissions until after Sept. 30, 2014.
A recent study conducted in Japan showed significant early post-administration improvements in sepsis patients who were given a single-dose administration of intravenous immune globulin (IVIG).
U.S. Health and Human Services announced $150 million in awards will be issued under the Affordable Care Act to support new full-time healthcenter delivery sites across the nation.
New research shows that women have a stronger immune response than men when given the flu vaccine, which may mean vaccinated women are better protected against catching the flu than vaccinated men.
Updates on CRA, Merk & Co., Pfizer, Amgen Inc., Incyte Corp., and more.
